Related Experiment Video
Updated: Oct 26, 2025
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Transcatheter mitral valve repair using the Cardioband® system: Histopathological insights in device ingrowth and
Martin O Schmiady1, Mathias Van Hemelrijck1, Maurizio Taramasso2
1Division of Cardiac Surgery, University Heart Center, University Hospital Zurich, Zurich, Switzerland.
Abstract:
Surgical implantation of a complete or incomplete ring to reduce the valve annulus and improve leaflet coaptation is the mainstay of mitral valve surgery. The Cardioband® system (Edwards Lifesciences) was designed to address the pathophysiological mechanism of annular dilatation through a catheter-based approach. We present the histopathological workup of a Cardioband® device, which had been implanted 21 months earlier in a 34-year-old male with ischemic cardiomyopathy. Device examination demonstrate a well-positioned and securely anchored device. The described tissue reactions may have an impact on choice of device and timing in case of re-do surgery.
